New Delhi: India has developed Rotavac, a rotavirus vaccine, at a price of around Rs 54 ($1) and it will hit the markets soon. The vaccine, developed in collaboration with Bharat Biotech under the Public-Private Partnership mode, is efficacious in ... Manorama Online, 4 days ago
DBT Announces Phase III Clinical Trial Results of Rotavirus Vaccine Developed in India Say Vaccine Demonstrates Strong Efficacy - Press Information Bureau, 5 days ago
India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine - News-Medical.Net, 5 days ago
A Phase III clinical trial of a rotavirus vaccine developed and manufactured in India has yielded positive results, the Government of India''s Department of Biotechnology (DBT) and Bharat Biotech have announced. Data from the trial, presented at the ...Times of India, 3 days ago India-developed rotavirus vaccine shows strong efficacy against childhood diarrhoea News Track India, 4 days ago
The show that has been enjoying the top spot on the small screen has surprisingly lost out to other crowd favourites in nominations for the prestigious Indian Telly Awards. Indeed, the show in question is Bade Acche Lagte Hain, which has bagged only ...Emirates247, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!